FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
Do food dyes make ADHD worse? Why some studies' findings spur food coloring bans
They're on the ingredient list of hundreds of thousands of branded food items, from Fruit Loops and Trix Cereal to Gatorade ...
Harris can’t snap her fingers and restore abortion rights. Here’s what she can do instead.
Harris promises to restore abortion rights if she is elected president. Among other things, she says she will see to it that ...
Medscape5h
Pfizer's Withdrawal of SCD Drug Raises Questions
Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...
The FDA Is Launching New Traceability Rules for Added Food Safety — and Everyone Is Confused
On January 20, 2026, the Food and Drug Administration's (FDA) new traceability rules — dubbed the Food Traceability Final ...
CNET2d
Salmonella and Listeria Found in Two Pet Food Brands: Everything to Know
While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.
We need a Food and Drug Administration for AI
We wouldn’t allow a new drug to be sold without thorough testing for safety and efficacy, so why should AI be any different?
FDA issues recall notices for two brands of pet food over salmonella and listeria contamination
Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...
FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk
Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the ...
Astria Therapeutics Receives FDA Orphan Drug Designation for Navenibart (STAR-0215) for the Treatment of Hereditary Angioedema
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that navenibart (STAR-0215) ...
STAT3h
Q&A: Why medical AI and value-based care may be made for each other
Stanford professor James Zou examined the clinical adoption of medical AI devices, and found that only a handful are being ...
US Food and Drug Administration approves 'Dupixent' for treatment of bronchitis
The US Food and Drug Administration FDA has approved French pharmaceutical company Sanofi Dupixent an anti-bronchitis drug ...